The Tuberculosis Drug Accelerator at year 10: what have we learned?

Aldridge, BB; Barros-Aguirre, D; Barry, CE; Bates, RH; Berthel, SJ; Boshoff, HI; Chibale, K; Chu, XJ; Cooper, CB; Dartois, V; Duncan, K; Fotouhi, N; Gusovsky, F; Hipskind, PA; Kempf, DJ; Lelievre, J; Lenaerts, AJ; McNamara, CW; Mizrahi, V; Nathan, C; Olsen, DB; Parish, T; Petrassi, HM; Pym, A; Rhee, KY; Robertson, GT; Rock, JM; Rubin, EJ; Russell, B; Russell, DG; Sacchettini, JC; Schnappinger, D; Schrimpf, M; Upton, AM; Warner, P; Wyatt, PG; Yuan, Y

Nathan, C (corresponding author), Weill Cornell Med, New York, NY 10065 USA.

NATURE MEDICINE, 2021; 27 (8): 1333

Abstract

The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索